A Phase I Trial and Pharmacokinetic Study of the Oral Platinum Analog Satraplatin in Children and Young Adults With Refractory Solid Tumours Including Brain Tumours.
Phase of Trial: Phase I
Latest Information Update: 19 May 2017
At a glance
- Drugs Satraplatin (Primary)
- Indications Brain cancer; Brain metastases; Solid tumours
- Focus Adverse reactions; Pharmacogenomic
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Dec 2010 New trial record